Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) posted its quarterly earnings data on Wednesday. The biotechnology company reported ($0.64) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.58), Zacks reports. The company had revenue of $290.38 million for the quarter, compared to analyst estimates of $285.35 million. Here are [...]
93pts. Had a couple of requests for this during the week, so here it is! 🌱 Vineyard: Lower Tintara, Kays Rd - originally planted by Thomas Hardy in the 1880s. 🪨 Soils: Maslin Sands, laid down ... Read Full Article →
New Delhi: Old Delhi's 13 protected monuments and their parts including Red Fort's Diwan-i-Aam, Mumtaz Mahal, Diwan-i-Khas, Delhi Gate, Ajmeri Gate an. Read Full Article →
New Delhi: Over a decade after a govt bank was allegedly duped of over Rs 4.1 crore in southwest Delhi's Najafgarh, the Central Bureau of Investigatio. Read Full Article →
iShares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names. That structure can offer more earnings visibility, but it also means giving up some upside when risk appetite shifts toward early-stage biotech companies. Read Full Article →
